Key result
Traditional risk factors remained associated with cardiovascular disease events across Europe over 20 years, with minor temporal hazard decreases for non-HDL cholesterol and systolic blood pressure.
Answers are grounded in this paper and cite their sources.
Traditional cardiovascular risk factors remain strongly associated with CVD incidence across Europe over a 20-year period, emphasizing the ongoing need for robust primary and secondary prevention strategies.
This editorial refers to ‘Regional and temporal differences in the associations between cardiovascular disease and its classic risk factors: an analysis of 49 cohorts from 11 European countries’ by J. Reinikainen et al., https://doi.org/10.1093/eurjpc/zwad359. Cardiovascular diseases (CVDs) remain the top 10 causes of morbidity and mortality around the world.1 Traditional risk factors [namely sex, smoking, diabetes, systolic blood pressure (SBP), non-high density lipoprotein (HDL) cholesterol, and body mass index (BMI)] have been accounted for a high proportion of incidence and prevalence of CVD, which can vary greatly per geographical location.1–3 Variation per region may depend on population characteristics, exposures, and outcome definitions.3 In spite of their variability, modifiable risk factors are globally associated with CVD.2,3 Recent global harmonized individual-level data have shown that the attribution of CVD incidence by traditional risk factors is ∼57% for women and 53% for men.4 In addition, CVD traditional risk factors attribution to all-cause mortality could be 22% for women and 19% for men.4 Decreases in the global burden of CVD in the last 50 years may have been achieved by primary and secondary prevention strategies and technologies. However, stagnation and even reversal of this trend have been observed, probably attributed to the increase of lifespan, higher time to exposure of traditional risk factors, and deterioration of lifestyle habits.4 In a world experiencing spinning changes in lifespan, environmental exposures, and behavioural changes, it is relevant to assess whether the role of CVD traditional risk factors remains across time and space in the incidence of CVD. In the current issue of the journal, Reinikainen et al.5 address this question by analysing over half a million European participants without previous CVD from 49 cohorts, representing 11 countries (central Europe: France, Germany, Lithuania, and Poland; northern Europe: Denmark, Finland, Norway, and Sweden; southern Europe: Italy and Spain; and the UK). They assessed the temporal and regional association of CVD traditional risk factors (sex, smoking, diabetes, systolic BP, non-HDL cholesterol, and BMI) and the incidence of CVD (including coronary heart disease and stroke).5 Cox proportional hazard models were fitted for each cohort and were adjusted for the other traditional risk factors. Reinikainen et al.5 found that in a time lapse of 20 years (1982–2012), CVD traditional risk factors remained associated to CVD events overall in Europe, irrespective of regional areas. In addition, minor temporal hazard decreases were observed for non-HDL cholesterol [7% per mmol/L; 95% confidence interval (CI), 3–10%] and SBP (4% per 20 mmHg; 95% CI, 1–8%), whereas a minor temporal hazard increase was observed for BMI (7% per 10 kg/m2; 95% CI, 1–13%).5 Even though minor temporal hazards reduction were observed for non-HDL cholesterol and SBP, they still remain the main associated factors for CVD incidence, prevalence, and mortality.4 In recent global harmonized individual data, CVD population-attributable fraction for SBP was 29% in women and 22% in men, followed by non-HDL cholesterol with 15% for women and 10% for men.4 In the PURE study, including more than 150 000 participants from a broad range of economic level countries, hypertension was the most associated risk factor to CVD with 22% population-attributable fraction, followed by high non-HDL cholesterol with 8% population-attributable fraction.3 The slight decrease in the association of SBP might be explained by the primary and secondary prevention strategies implemented in the European region in the last decades. In a comparable time (1990–2019), a study including worldwide data from 104 million people from 184 countries showed that the number of people with hypertension increased.6 However, in the European region, undiagnosed cases have been reduced by half and optimal treatment has been increased by more than five-fold.6 Similarly, the slight decrease in the hazards ratio for non-HDL cholesterol might be explained by the reduction of non-HDL cholesterol levels driven by primary and secondary prevention strategies. In a comparable time (1980–2018), a study including 102.6 million individuals, from 200 countries with cholesterol level measures, showed that in the European region, non-HDL cholesterol levels have been reduced by over 20%.7 Increases in the hazards ratio for BMI might reflect the global increase in obesity incidence in the last 20 years, particularly for men (2000–2019).8 Cardiovascular disease population-attributable fraction for BMI has been shown to be 7.6% in both men and women.4 Despite this similarity, obesity-related mortality is expected to increase in the upcoming decade by 40% only in men.8 This increase is due to men showing more diabetes, insulin resistance, and ectopic fat levels at the same BMI levels as compared to women.8 It is demonstrated that many aspects of energy and glucose homeostasis are regulated differently in men and women, affecting their predisposition to diabetes and related metabolic disorders.9 Even though not fully clear, underlying mechanisms primarily include sex steroid hormones and sex chromosomes, with additional contribution from sex specificities in foetal/neonatal programming and epigenetic changes.9 Harmonizing cohorts to the individual-level data provide better exploration of heterogeneity among studies. However, standardization of the definitions may be cumbersome. Repeated measures of SBP are a better representation of single measures, creating misclassification of individuals, which might lead to an underestimation of the associated risks. Although traditional risk factors explain a great portion of CVD, a fifth of the population presenting with a CVD event do not report any of these risk factors.10,11 Studies including pooled information from randomized controlled trials and from case–control subjects have shown that between 0% and 30% of the population with CVD events do not report traditional risk factors, varying in type of population selected, region, and sex.10,11 This suggests underlying cardiovascular ageing processes and additional factors that deviate from cardiovascular health and have not been adequately taken into account12 (Graphical Abstract). Altogether, the findings presented by M. Reinikainen and colleagues highlight the relevance of strengthening prevention programmes of traditional risk factors in order to reduce CVD and also highlight the need of collective and detailed efforts to explore novel risk factors or population (e.g. gender) specific factors. Additional efforts should be taken into exploring cardiovascular aging, which may englobe the cardiovascular effects of both traditional and non-traditional risk factors (Graphical Abstract). Finally, embracing novel efforts to integrate information collected through wearables and other novel technological means, with existing data sources, is essential to identify the roots and causes of CVD in specific populations. The future demands novel efforts, and the pandemic of CVD cannot wait to be halted. V.A.A. received funding from the Swiss National Science Foundation under grant number 189235 for the LYRICA (Lifestyle Prevention of Cardiovascular Ageing) project. S.B. received funding for post-doctoral researcher studies by the Swiss National Science Foundation (SNSF IZSTZ0_190277). No new data were generated or analysed in support of this research.
No takes yet. Share an insight, caveat, or question.
Arita et al. (2023) conducted an editorial in Cardiovascular disease (n=500,000). Traditional cardiovascular risk factors was evaluated on Incidence of cardiovascular disease (including coronary heart disease and stroke). Traditional risk factors remained associated with cardiovascular disease events across Europe over 20 years, with minor temporal hazard decreases for non-HDL cholesterol and systolic blood pressure.
Synapse has enriched 10 related papers. Consider them for comparative context: